106 related articles for article (PubMed ID: 36046390)
1. High incidence of null variants identified from newborn screening of X-linked adrenoleukodystrophy in Taiwan.
Chen HA; Hsu RH; Chen PW; Lee NC; Chiu PC; Hwu WL; Chien YH
Mol Genet Metab Rep; 2022 Sep; 32():100902. PubMed ID: 36046390
[TBL] [Abstract][Full Text] [Related]
2. Newborn screening for X-linked adrenoleukodystrophy in Italy: Diagnostic algorithm and disease monitoring.
Bonaventura E; Alberti L; Lucchi S; Cappelletti L; Fazzone S; Cattaneo E; Bellini M; Izzo G; Parazzini C; Bosetti A; Di Profio E; Fiore G; Ferrario M; Mameli C; Sangiorgio A; Masnada S; Zuccotti GV; Veggiotti P; Spaccini L; Iascone M; Verduci E; Cereda C; Tonduti D;
Front Neurol; 2022; 13():1072256. PubMed ID: 36698902
[TBL] [Abstract][Full Text] [Related]
3. Plasma C24:0- and C26:0-lysophosphatidylcholines are reliable biomarkers for the diagnosis of peroxisomal β-oxidation disorders.
Morales-Romero B; González de Aledo-Castillo JM; Fernández Sierra C; Martínez Carreira C; Zaragoza Bonet C; Fernández Bonifacio R; Caro Miró MA; Argudo-Ramírez A; López Galera RM; García-Villoria J
J Lipid Res; 2024 Mar; 65(3):100516. PubMed ID: 38320654
[TBL] [Abstract][Full Text] [Related]
4. Childhood Cerebral Adrenoleukodystrophy: Case Report and Literature Review Advocating for Newborn Screening.
Rajakumar HK; Coimbatore Sathyabal V; Nachiappan R; Krishnaswamy Vijayaramanujam S
Degener Neurol Neuromuscul Dis; 2024; 14():75-83. PubMed ID: 38912366
[TBL] [Abstract][Full Text] [Related]
5. Neonatal detection of Aicardi Goutières Syndrome by increased C26:0 lysophosphatidylcholine and interferon signature on newborn screening blood spots.
Armangue T; Orsini JJ; Takanohashi A; Gavazzi F; Conant A; Ulrick N; Morrissey MA; Nahhas N; Helman G; Gordish-Dressman H; Orcesi S; Tonduti D; Stutterd C; van Haren K; Toro C; Iglesias AD; van der Knaap MS; Goldbach Mansky R; Moser AB; Jones RO; Vanderver A
Mol Genet Metab; 2017 Nov; 122(3):134-139. PubMed ID: 28739201
[TBL] [Abstract][Full Text] [Related]
6. The Changing Face of Adrenoleukodystrophy.
Zhu J; Eichler F; Biffi A; Duncan CN; Williams DA; Majzoub JA
Endocr Rev; 2020 Aug; 41(4):577-93. PubMed ID: 32364223
[TBL] [Abstract][Full Text] [Related]
7. Corrigendum: Newborn screening for X-linked adrenoleukodystrophy in Italy: diagnostic algorithm and disease monitoring.
Bonaventura E; Alberti L; Lucchi S; Cappelletti L; Fazzone S; Cattaneo E; Bellini M; Izzo G; Parazzini C; Bosetti A; Di Profio E; Fiore G; Ferrario M; Mameli C; Sangiorgio A; Masnada S; Zuccotti GV; Veggiotti P; Spaccini L; Iascone M; Verduci E; Cereda C; Tonduti D;
Front Neurol; 2024; 15():1376447. PubMed ID: 38510379
[TBL] [Abstract][Full Text] [Related]
8. [Peroxisomal neurologic diseases and Refsum disease: very long chain fatty acids and phytanic acid as diagnostic markers].
Molzer B; Stöckler S; Bernheimer H
Wien Klin Wochenschr; 1992; 104(21):665-70. PubMed ID: 1282286
[TBL] [Abstract][Full Text] [Related]
9. Early Detection of Adrenal Insufficiency: The Impact of Newborn Screening for Adrenoleukodystrophy.
Ramirez Alcantara J; Grant NR; Sethuram S; Nagy A; Becker C; Sahai I; Stanley T; Halper A; Eichler FS
J Clin Endocrinol Metab; 2023 Oct; 108(11):e1306-e1315. PubMed ID: 37220095
[TBL] [Abstract][Full Text] [Related]
10. Generating human AMN and cALD iPSC-derived astrocytes with potential for modeling X-linked adrenoleukodystrophy phenotypes.
Kaur N; Singh J
bioRxiv; 2024 Jun; ():. PubMed ID: 38854155
[TBL] [Abstract][Full Text] [Related]
11. Low donor chimerism may be sufficient to prevent demyelination in adrenoleukodystrophy.
Ikeda T; Kawahara Y; Miyauchi A; Niijima H; Furukawa R; Shimozawa N; Morimoto A; Osaka H; Yamagata T
JIMD Rep; 2022 Jan; 63(1):19-24. PubMed ID: 35028267
[TBL] [Abstract][Full Text] [Related]
12. Four-dimensional lipidomics profiling in X-linked adrenoleukodystrophy using trapped ion mobility mass spectrometry.
Jaspers YRJ; Meyer SW; Pras-Raves ML; Dijkstra IME; Wever EJM; Dane AD; van Klinken JB; Salomons GS; Houtkooper RH; Engelen M; Kemp S; Van Weeghel M; Vaz FM
J Lipid Res; 2024 Jun; 65(6):100567. PubMed ID: 38795862
[TBL] [Abstract][Full Text] [Related]
13. Recurrent episodes of vomiting and diarrhoea in a male child: a rare presentation of X-linked adrenoleukodystrophy.
Gupta P; Keller SR; Patterson B
BMJ Case Rep; 2022 Aug; 15(8):. PubMed ID: 35948360
[TBL] [Abstract][Full Text] [Related]
14. Central precocious puberty in a boy with X-linked adrenoleukodystrophy caused by a novel
Zhao C; Zhu H; Wang J; Liu W; Xue Y; Hu Y
Heliyon; 2024 Apr; 10(7):e28987. PubMed ID: 38596053
[TBL] [Abstract][Full Text] [Related]
15. In vivo adenine base editing rescues adrenoleukodystrophy in a humanized mouse model.
Gopalappa R; Lee M; Kim G; Jung ES; Lee H; Hwang HY; Lee JG; Kim SJ; Yoo HJ; Sung YH; Kim D; Baek IJ; Kim HH
Mol Ther; 2024 May; ():. PubMed ID: 38796705
[TBL] [Abstract][Full Text] [Related]
16. Multi-Omic Approach to Identify Phenotypic Modifiers Underlying Cerebral Demyelination in X-Linked Adrenoleukodystrophy.
Richmond PA; van der Kloet F; Vaz FM; Lin D; Uzozie A; Graham E; Kobor M; Mostafavi S; Moerland PD; Lange PF; van Kampen AHC; Wasserman WW; Engelen M; Kemp S; van Karnebeek CDM
Front Cell Dev Biol; 2020; 8():520. PubMed ID: 32671069
[TBL] [Abstract][Full Text] [Related]
17. Pain Study in X-Linked Adrenoleukodystrophy in Males and Females.
Bachiocco V; Cappa M; Petroni A; Salsano E; Bizzarri C; Ceccarelli I; Cevenini G; Pensato V; Aloisi AM
Pain Ther; 2021 Jun; 10(1):505-523. PubMed ID: 33609269
[TBL] [Abstract][Full Text] [Related]
18. The pathology of X-linked adrenoleukodystrophy: tissue specific changes as a clue to pathophysiology.
Yska HAF; Engelen M; Bugiani M
Orphanet J Rare Dis; 2024 Mar; 19(1):138. PubMed ID: 38549180
[TBL] [Abstract][Full Text] [Related]
19. A case of female adrenoleukodystrophy carrier with insidious neurogenic bladder.
Obara K; Abe E; Shimozawa N; Toyoshima I
J Gen Fam Med; 2020 Jul; 21(4):146-147. PubMed ID: 32742905
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
